CGAS and Parkinson disease: Given the role of cGAS and STING in the cell senescence and aging process, it is likely that targeting this signalling could yield a synergistic improvement in age-related neurodegenerative condition like PD, nevertheless this requires further characterisation of the drug molecules regarding the safety and pharmacokinetic profiles (Huang et al., 2023; Decout et al., 2021).